CVRdatabase
Menu

Pharmanovia A/S

Public limited companyCVR 32287824København SActive

Pharmanovia A/S is a public limited company, based in København S, active in wholesale of pharmaceutical goods and nursing supplies, founded in 2009. Net profit rose 101% from 2025 to 2026, ending at DKK 7.7m. Profit has grown three years in a row. Equity grew to DKK 15.8m in 2026.

Follow
PDF reportCompare

Key figures · financial year 2026

Gross profitDKK 11.7m+94.8% vs. 2025
Net profitDKK 7.7m+101.4% vs. 2025
EquityDKK 15.8m+95.6% vs. 2025
Employees3latest month from CVR

What has changed

calculated from recorded figures and dates

Financials: 2026 against 2025

  • Gross profit rose 95% (2025 → 2026), to DKK 11.7m.
  • Net profit rose 101% (2025 → 2026), to DKK 7.7m.
  • Equity rose 96% (2025 → 2026), to DKK 15.8m.

Employees

  • 2 fewer employees than a year earlier: 3 (08/2026) against 5 (08/2025).

Management and owners, last 24 months

  • New in management: Twan Johannes Anna Nouwen (board member, 17/02/2026), Christoph Michael Habereder (board member, 17/02/2026) and Mohammad Muqtadir Samy (chair of the board, 24/03/2026) (+5).
  • Stepped down: Amit Vijaykumar Patel (chair of the board, 24/03/2026), Neeshe Bhikhubhai Williams (board member, 09/06/2026) and James Charles Burt (board member, 01/05/2025) (+6).

Calculated from the latest two annual reports in sequence and from registrations in CVR. A figure that is missing in either year gives no line, and we derive no figures.

Financial statements

Financial years 2021–2026 · amounts in DKK thousand

Equity and net profit

−DKK 30m−DKK 20m−DKK 10mDKK 0DKK 10mDKK 20mDKK 30m202120222023202420252026
EquityNet profit
Financial figures for Pharmanovia A/S
202120222023202420252026Change
Revenuenot statednot statednot statednot statednot statednot stated–
Gross profit15,2243,43143,9844,6846,02511,735+94.8%
Operating profit (EBIT)−1,799−20,13624,9242,9253,7049,248+149.7%
Profit before tax−2,028−21,60024,4552,6833,8329,795+155.6%
Net profit−2,028−21,60026,1312,2473,8397,731+101.4%
Total assets27,91276,094136,72847,72839,94132,312−19.1%
Equity15,110−6,49119,6404,8838,09015,821+95.6%
Liabilities12,80382,585117,08842,84431,57616,492−47.8%
Cash and cash equivalents42214,7569,0462,0211,5961,626+1.9%
Average number of employees15181512129−25%

Source: annual reports filed with the Danish Business Authority (XBRL). Figures for the company (not the group); change is the latest year against the year before. “–” means the figure is not stated in the annual report. Revenue is not stated for 2021, 2022, 2023, 2024, 2025, 2026: smaller companies may omit it, and we do not derive it from other figures.

Download the figures as CSV · free with an account, amounts in whole DKK

DKK 0DKK 10mDKK 20mDKK 30mDKK 40m202120222023202420252026
Gross profitMedian, the industry (232 companies)

Signals from the financial statements

calculated from the 2026 figures

  • Fewer employees

    The number of employees fell 25% from 12 in 2025 to 9 in 2026.

    How is this calculated?

    The number of employees according to the annual report has fallen by at least 25%, and was at least 10 the year before.

The signals are rules applied to the figures in the annual reports. They are not an assessment or credit rating of the company. See Data and method.

Annual reports

6 financial years
Annual reports for Pharmanovia A/S
Financial yearPeriodPublishedFigures forDocuments
202601/04/2025 – 31/03/202630/09/2026The companyPDF not statedXBRL
202501/04/2024 – 31/03/202502/11/2025The companyPDF not statedXBRL
202401/04/2023 – 31/03/202404/11/2024The companyPDFXBRL
202301/04/2022 – 31/03/202306/10/2023The companyPDFXBRL
202201/04/2021 – 31/03/202202/09/2022The companyPDFXBRL
202101/04/2020 – 31/03/202114/09/2021The companyPDFXBRL

The figures from all the annual reports are shown on this page. The documents themselves (PDF and XBRL, the machine-readable edition) are downloaded with a Pro account: sign in or create a free account, and then choose Pro. XBRL is the edition the figures on the page are read from.

Employees

monthly figures from CVR
02468101209/2310/2311/2312/2301/2402/2403/2404/2405/2406/2407/2408/2409/2410/2411/2412/2401/2502/2503/2504/2505/2506/2507/2508/2509/2510/2511/2512/2501/2602/2603/2604/2605/2606/2607/2608/26
Employees

Position in the industry

232 companies in the database

Comparison with the other companies in wholesale of pharmaceutical goods and nursing supplies based on the latest financial year.

Gross profitDKK 11.7mNo. 115 of 232
Better than 51% of the companies in the industry
EquityDKK 15.8mNo. 104 of 232
Better than 55% of the companies in the industry
Number of employees3No. 114 of 232
Better than 51% of the companies in the industry

Industry median: gross profit DKK 11.2m, net profit DKK 1.8m, equity DKK 9.6m, 9 employees.

DKK 100kDKK 1.4mDKK 19.1mDKK 263.2mDKK 1.5bnHere
Distribution of gross profit for 225 companies in the industry (latest financial year, logarithmic scale). Amber bar: where this company sits.

Compared with similar companies

size, age and company form
Rank among similar companies
GroupGross profitEquity
Companies with fewer than 20 employees69,967 companies in the comparison
No. 3,651of 69,742
Better than 95%
No. 6,762of 69,964
Better than 90%
Same industry and fewer than 20 employees150 companies in the comparison
No. 36of 150
Better than 77%
No. 33of 150
Better than 79%
Companies that are between 15 and 29 years old24,910 companies in the comparison
No. 5,276of 24,791
Better than 79%
No. 5,106of 24,909
Better than 80%
All companies of type A/S18,025 companies in the comparison
No. 8,268of 17,786
Better than 54%
No. 7,019of 18,024
Better than 61%

The rank is calculated among companies in the database with a figure for the latest financial year, and is shown only for groups of at least ten companies.

Compare with the industry

Wholesale of pharmaceutical goods and nursing supplies
Gross profit
  1. Pharmanovia A/SDKK 11.7m
  2. Ambu A/SDKK 3.6bn
  3. Stada Nordic ApSDKK 687m
Net profit
  1. Pharmanovia A/SDKK 7.7m
  2. Ambu A/SDKK 609m
  3. Stada Nordic ApSDKK 54.6m
Equity
  1. Pharmanovia A/SDKK 15.8m
  2. Ambu A/SDKK 6bn
  3. Stada Nordic ApSDKK 346.3m
Employees
  1. Pharmanovia A/S3
  2. Ambu A/S619
  3. Stada Nordic ApS51

Latest financial year per company. Choose up to three companies from the largest in the industry.

Owners and group

from the Public Ownership Register
Owners
  • Atnahs Pharma UK Limited100%
Pharmanovia A/S

Management

4 active registrations

Executive management

Executive management at Pharmanovia A/S
NameRoleAppointed
Christoph Michael HaberederDirector09/06/2026

Board of directors

Board of directors at Pharmanovia A/S
NameRoleAppointed
Twan Johannes Anna NouwenBoard member17/02/2026
Christoph Michael HaberederBoard member17/02/2026
Mohammad Muqtadir SamyChair of the board24/03/2026
Founders
NM af 18. Juni 2009 A/S
Former management (27)
Former management at Pharmanovia A/S
NameRoleAppointedResigned
Birgitte StenbjerreLiquidator28/05/201014/09/2011
Mads Christian OlesenBoard member14/09/201131/03/2016
Mads Renlef HenningsenCEO01/01/201331/10/2013
Birgitte StenbjerreBoard member01/01/201331/03/2016
Svend Aage JohansenCEO01/11/201323/05/2014
Svend Aage JohansenChair of the board23/05/201431/12/2015
Bent Benny AndersenBoard member23/05/201431/12/2015
Bent Benny AndersenCEO23/05/201401/01/2016
Svend Aage JohansenBoard member01/01/201628/02/2019
Svend Aage JohansenCEO01/01/201628/02/2019
Bent Benny AndersenChair of the board01/01/201631/03/2016
Amit Vijaykumar PatelChair of the board31/03/201624/03/2026
Dipen Vijaykumar PatelDeputy chair31/03/201607/08/2019
Anthony Charles PlayleBoard member31/03/201624/02/2020
Jesper Wilhelm VossDirector28/02/201906/10/2023
Mark John CotterillBoard member28/02/201907/08/2019
Neeshe Bhikhubhai WilliamsBoard member07/08/201909/06/2026
Rishi BhikhuBoard member07/08/201929/03/2022
Alastair Thomas Badgett HayBoard member07/08/201917/12/2021
Felipe Andres Florez ArangoBoard member16/06/202124/05/2023
James Charles BurtBoard member17/12/202101/05/2025
James Sang Bum LeeBoard member24/05/202330/09/2025
James Sang Bum LeeDirector06/10/202330/09/2025
Zubair JaveedBoard member01/05/202530/09/2025
Santsagar PatelBoard member01/05/202517/02/2026
Neeshe Bhikhubhai WilliamsDirector30/09/202509/06/2026
Mohammad Muqtadir SamyBoard member17/02/202623/03/2026

Signing rule: Selskabet tegnes af bestyrelsens medlemmer hver for sig eller af en direktør alene.

Address and production units

1 active production units

Ørestads Boulevard 108
2300 København S

København Municipality · Postcode 2300

Production units
Production unitAddressEmployeesP number
Pharmanovia A/SØrestads Boulevard 108, 5, 2300 København S31015388478

Purpose

Selskabets formål er at drive handelsvirksomhed med farmaceutiske produkter, herunder udvikling, salg, distribution og markedsføring af farmaceutiske produkter og dermed beslægtet virksomhed.

The purpose is quoted from the register in Danish.

Changes year by year

85 registered events
202611 changesaccounts 1 · management 10
  • Annual report for 2026 published
  • Christoph Michael Habereder appointed director
  • Neeshe Bhikhubhai Williams stepped down as director
  • Neeshe Bhikhubhai Williams stepped down as board member
  • Mohammad Muqtadir Samy appointed chair of the board
  • Amit Vijaykumar Patel stepped down as chair of the board
  • Mohammad Muqtadir Samy stepped down as board member
  • Christoph Michael Habereder appointed board member
  • Twan Johannes Anna Nouwen appointed board member
  • Mohammad Muqtadir Samy appointed board member
  • Santsagar Patel stepped down as board member
20258 changesaccounts 1 · management 7
  • Annual report for 2025 published
  • Neeshe Bhikhubhai Williams appointed director
  • Zubair Javeed stepped down as board member
  • James Sang Bum Lee stepped down as director
  • James Sang Bum Lee stepped down as board member
  • Santsagar Patel appointed board member
  • Zubair Javeed appointed board member
  • James Charles Burt stepped down as board member
20241 changeaccounts 1
  • Annual report for 2024 published
20235 changesmanagement 4 · accounts 1
  • James Sang Bum Lee appointed director
  • Jesper Wilhelm Voss stepped down as director
  • Annual report for 2023 published
  • James Sang Bum Lee appointed board member
  • Felipe Andres Florez Arango stepped down as board member
20222 changesaccounts 1 · management 1
  • Annual report for 2022 published
  • Rishi Bhikhu stepped down as board member
20215 changesmanagement 3 · accounts 1 · name 1
  • James Charles Burt appointed board member
  • Alastair Thomas Badgett Hay stepped down as board member
  • Annual report for 2021 published
  • Name changed from Atnahs Pharma Nordics A/S to Pharmanovia A/S
  • Felipe Andres Florez Arango appointed board member
20202 changesname 1 · management 1
  • Name changed from PHARMANOVIA A/S to Atnahs Pharma Nordics A/S
  • Anthony Charles Playle stepped down as board member
20199 changesmanagement 9
  • Neeshe Bhikhubhai Williams appointed board member
  • Rishi Bhikhu appointed board member
  • Alastair Thomas Badgett Hay appointed board member
  • Mark John Cotterill stepped down as board member
  • Dipen Vijaykumar Patel stepped down as deputy chair
  • Mark John Cotterill appointed board member
  • Jesper Wilhelm Voss appointed director
  • Svend Aage Johansen stepped down as ceo
  • Svend Aage Johansen stepped down as board member
20186 changesaddress 1 · ownership 5
  • Moved to Ørestads Boulevard 108, 5, 2300 København S
  • Atnahs Pharma UK Limited registered as owner (100%)
  • Svend Aage Johansen is no longer registered as owner
  • Atnahs Pharma UK Limited is no longer registered as owner
  • Svend Aage Johansen registered as owner (33.33%)
  • Java Holding ApS is no longer registered as owner
201617 changesownership 5 · capital 2 · management 10
  • Java Holding ApS registered as owner (33.33%)
  • CHRISJOPALI ApS is no longer registered as owner
  • Share capital changed from 1,000,000 DKK to 1,000,001 DKK
  • Share capital changed from 500,000 DKK to 1,000,000 DKK
  • Amit Vijaykumar Patel appointed chair of the board
  • Anthony Charles Playle appointed board member
  • Dipen Vijaykumar Patel appointed deputy chair
  • Bent Benny Andersen stepped down as chair of the board
  • Birgitte Stenbjerre stepped down as board member
  • Mads Christian Olesen stepped down as board member
  • CHRISJOPALI ApS registered as owner (33.33%)
  • Atnahs Pharma UK Limited registered as owner (50%)
  • NM AF 18. JUNI 2009 A/S is no longer registered as owner
  • Svend Aage Johansen appointed ceo
  • Bent Benny Andersen appointed chair of the board
  • Svend Aage Johansen appointed board member
  • Bent Benny Andersen stepped down as ceo
20152 changesmanagement 2
  • Svend Aage Johansen stepped down as chair of the board
  • Bent Benny Andersen stepped down as board member
20144 changesmanagement 4
  • Svend Aage Johansen appointed chair of the board
  • Bent Benny Andersen appointed ceo
  • Bent Benny Andersen appointed board member
  • Svend Aage Johansen stepped down as ceo
20135 changesmanagement 4 · name 1
  • Svend Aage Johansen appointed ceo
  • Mads Renlef Henningsen stepped down as ceo
  • Name changed from NORDMEDICA INTERNATIONAL A/S to PHARMANOVIA A/S
  • Birgitte Stenbjerre appointed board member
  • Mads Renlef Henningsen appointed ceo
20121 changeindustry 1
  • Industry changed to Wholesale of pharmaceutical goods and nursing supplies (464610)
20113 changesname 1 · status 1 · management 1
  • Name changed from NMAS A/S to NORDMEDICA INTERNATIONAL A/S
  • Status changed to active
  • Mads Christian Olesen appointed board member
20102 changesaddress 1 · status 1
  • Moved to Jægersborg Alle 164, 2820 Gentofte
  • Status changed to in voluntary liquidation
20092 changesfounded 1 · ownership 1
  • Registered as NMAS A/S
  • NM AF 18. JUNI 2009 A/S registered as owner (100%)

Related companies

Same industry in København

See all →

Same people in management

Largest in the industry

See all →

Source and updates

The information comes from the Danish Central Business Register (Danish Business Authority) and from annual reports filed with the Danish Business Authority. Last synchronised 24/10/2026. The company is protected against advertising; contact details are not shown, and the data must not be used for marketing.

View in CVRReport a correction